IndSwift

« Back

Unaudited Financial Results for the Quarter ended 30th September, 2008

(RS. IN LACS)

PARTICULARS	Unaudited Qtr. ended	Unaudited Qtr. ended	Unaudited half Year ended	Unaudited half Year ended year	Audited year ended
	30.09.08	30.09.07	30.09.08	30.09.07	31.03.08

INCOME FROM OPERATIONS	14608.43	12244.97	27446.28	23314.50	51560.36
OTHER INCOME	41.05	28.72	58.42	45.17	361.08
TOTAL INCOME	14649.48	12273.69	27504.70	23359.67	51921.44

EXPENDITURE
DECREASE IN STOCK IN TRADE	-301.10	-1452.45	-1248.39	237.84	-4705.44
CONSUMPTION OF RAW MATERIAL	6441.20	6428.69	11199.15	8607.01	22277.91
COST OF SALES	4443.71	4024.28	9943.47	8263.98	22277.91
STAFF COST	478.63	411.36	918.75	789.03	1659.93
OTHER EXPENSES	260.00	110.00	440.00	220.00	585.60
TOTAL EXPENDITURE	12701.95	10791.25	23873.31	20539.56	45117.05
INTEREST	826.83	619.56	1624.52	1177.49	2954.56
PROFIT BEFORE TAX	1120.70	862.88	2006.87	1642.62	3849.83
PROVISION FOR TAX(INCL.FBT)	141.97	107.76	257.37	206.10	433.94
PROVISION FOR DEFFERED TAX	100.00	100.00	250.00	250.00	291.34
NET PROFIT	878.73	655.12	1499.50	1186.52	3124.55
SHARE CAPITAL	743.57	743.57	743.57	743.57	743.57
PUBLIC SHARE HOLDING
No. OF SHARES	23578735	23931582	23578735	23931582	23633517
% AGE OF TOTAL HOLDING	63.42	64.37	63.42	64.37	63.57

NOTES:
1. During the quarter under review, the Income of the company has grown 19.36% and Profit Before Tax has shown an increase of 29.88% as compared to the same period in the previous year. 2.The company is exclusively in the pharamaceutical business segment only. 3.Information on investor's Complaints for the quarter: Opening: nil, Received: 2, Pending:Nil 4.Previous period figures have been re-grouped/ or rearranged wherever necessary. 5. The above results were taken on record by the Audit Committee and Board of Directors at their respective meetings held on 29th October 2007

By the order of the Board

Sd/-

Dated: 25.10.2008		(S.R. Mehta)

Place: Chandigarh		Chairman